SEC Comment Letter for Verastem, Inc. (VSTM) (CIK 0001526119) (VSTM) — Jul 31, 2018
Verastem, Inc. (VSTM) (CIK 0001526119)
Date: July 31, 2018 · CIK: 0001526119 · Accession: 0000000000-18-023655
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226322
Letter
July 31, 2018 Robert Forrester President and Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, MA 02494 Re:Verastem, Inc. Registration Statement on Form S-3 Filed July 24, 2018 File No. 333-226322 Dear Mr. Forrester: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Thomas J. Danielski, Esq.
Show Raw Text
July 31, 2018
Robert Forrester
President and Chief Executive Officer
Verastem, Inc.
117 Kendrick Street, Suite 500
Needham, MA 02494
Re:Verastem, Inc.
Registration Statement on Form S-3
Filed July 24, 2018
File No. 333-226322
Dear Mr. Forrester:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Thomas J. Danielski, Esq.